-
1
-
-
84855792427
-
Cancer statistics, 2012
-
Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62, 10-29.
-
(2012)
CA Cancer J. Clin.
, vol.62
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
58149132633
-
Locally advanced non-small cell lung cancer: The past, present, and future
-
Govindan, R.; Bogart, J.; Vokes, E.E. Locally advanced non-small cell lung cancer: The past, present, and future. J. Thorac. Oncol. 2008, 3, 917-928.
-
(2008)
J. Thorac. Oncol.
, vol.3
, pp. 917-928
-
-
Govindan, R.1
Bogart, J.2
Vokes, E.E.3
-
3
-
-
24344501624
-
Pathogenesis of lung cancer: 100 year report
-
Miller, Y.E. Pathogenesis of lung cancer: 100 year report. Am. J. Respir. Cell Mol. Biol. 2005, 33, 216-223.
-
(2005)
Am. J. Respir. Cell Mol. Biol.
, vol.33
, pp. 216-223
-
-
Miller, Y.E.1
-
4
-
-
77958190279
-
Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer
-
Barak, V.; Holdenrieder, S.; Nisman, B.; Stieber, P. Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer. Cancer Biomark. 2010, 6, 191-196.
-
(2010)
Cancer Biomark.
, vol.6
, pp. 191-196
-
-
Barak, V.1
Holdenrieder, S.2
Nisman, B.3
Stieber, P.4
-
5
-
-
77958162955
-
Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer
-
Holdenrieder, S.; Nagel, D.; Stieber, P. Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer. Cancer Biomark. 2010, 6, 179-190.
-
(2010)
Cancer Biomark.
, vol.6
, pp. 179-190
-
-
Holdenrieder, S.1
Nagel, D.2
Stieber, P.3
-
6
-
-
0024581504
-
Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer
-
Jorgensen, L.G.; Hansen, H.H.; Cooper, E.H. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur. J. Cancer Clin. Oncol. 1989, 25, 123-128.
-
(1989)
Eur. J. Cancer Clin. Oncol.
, vol.25
, pp. 123-128
-
-
Jorgensen, L.G.1
Hansen, H.H.2
Cooper, E.H.3
-
7
-
-
79957528306
-
Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer
-
Petrovic, M.; Baskic, D.; Bankovic, D.; Ilic, N. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer. Biomarkers 2011, 16, 311-320.
-
(2011)
Biomarkers
, vol.16
, pp. 311-320
-
-
Petrovic, M.1
Baskic, D.2
Bankovic, D.3
Ilic, N.4
-
8
-
-
84878470684
-
Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib
-
Wang, Y.; Tang, D.; Sui, A.; Jiao, W.; Luo, Y.; Wang, M.; Yang, R.; Wang, Z.; Shen, Y. Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib. Clin. Transl. Oncol. 2013, 15, 384-390.
-
(2013)
Clin. Transl. Oncol.
, vol.15
, pp. 384-390
-
-
Wang, Y.1
Tang, D.2
Sui, A.3
Jiao, W.4
Luo, Y.5
Wang, M.6
Yang, R.7
Wang, Z.8
Shen, Y.9
-
9
-
-
0029032851
-
Preoperative CA 125: An independent prognostic factor in patients with stage I epithelial ovarian cancer
-
Nagele, F.; Petru, E.; Medl, M.; Kainz, C.; Graf, A.H.; Sevelda, P. Preoperative CA 125: An independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol. 1995, 86, 259-264.
-
(1995)
Obstet Gynecol
, vol.86
, pp. 259-264
-
-
Nagele, F.1
Petru, E.2
Medl, M.3
Kainz, C.4
Graf, A.H.5
Sevelda, P.6
-
10
-
-
30744470421
-
New tumor markers: CA125 and beyond
-
Bast, R.C., Jr.; Badgwell, D.; Lu, Z.; Marquez, R.; Rosen, D.; Liu, J.; Baggerly, K.A.; Atkinson, E.N.; Skates, S.; Zhang, Z.; et al. New tumor markers: CA125 and beyond. Int. J. Gynecol. Cancer 2005, 15, 274-281.
-
(2005)
Int. J. Gynecol. Cancer
, vol.15
, pp. 274-281
-
-
Bast Jr., R.C.1
Badgwell, D.2
Lu, Z.3
Marquez, R.4
Rosen, D.5
Liu, J.6
Baggerly, K.A.7
Atkinson, E.N.8
Skates, S.9
Zhang, Z.10
-
11
-
-
79959610405
-
Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC)
-
Cedres, S.; Nunez, I.; Longo, M.; Martinez, P.; Checa, E.; Torrejón, D.; Felip, E. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clin. Lung Cancer 2011, 12, 172-179.
-
(2011)
Clin. Lung Cancer
, vol.12
, pp. 172-179
-
-
Cedres, S.1
Nunez, I.2
Longo, M.3
Martinez, P.4
Checa, E.5
Torrejón, D.6
Felip, E.7
-
12
-
-
0019968599
-
Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer
-
Kato, H.; Morioka, H.; Tsutsui, H.; Aramaki, S.; Torigoe, T. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer 1982, 50, 1294-1296.
-
(1982)
Cancer
, vol.50
, pp. 1294-1296
-
-
Kato, H.1
Morioka, H.2
Tsutsui, H.3
Aramaki, S.4
Torigoe, T.5
-
13
-
-
48049105367
-
A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer
-
Kagohashi, K.; Satoh, H.; Ishikawa, H.; Ohtsuka, M.; Sekizawa, K. A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer. Med. Oncol. 2008, 25, 187-189.
-
(2008)
Med. Oncol.
, vol.25
, pp. 187-189
-
-
Kagohashi, K.1
Satoh, H.2
Ishikawa, H.3
Ohtsuka, M.4
Sekizawa, K.5
-
14
-
-
0026660504
-
Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma
-
Niklinski, J.; Furman, M.; Laudanski, J.; Kozlowski, M. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma. Neoplasma 1992, 39, 279-282.
-
(1992)
Neoplasma
, vol.39
, pp. 279-282
-
-
Niklinski, J.1
Furman, M.2
Laudanski, J.3
Kozlowski, M.4
-
15
-
-
0028858107
-
CEA, CYFRA21-1 and SCC in non-small cell lung cancer
-
Moro, D.; Villemain, D.; Vuillez, J.P.; Delord, C.A.; Brambilla, C. CEA, CYFRA21-1 and SCC in non-small cell lung cancer. Lung Cancer 1995, 13, 169-176.
-
(1995)
Lung Cancer
, vol.13
, pp. 169-176
-
-
Moro, D.1
Villemain, D.2
Vuillez, J.P.3
Delord, C.A.4
Brambilla, C.5
-
16
-
-
0037274950
-
Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer
-
Schneider, J.; Philipp, M.; Salewski, L.; Velcovsky, H.G. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Clin. Lab. 2003, 49, 35-42.
-
(2003)
Clin. Lab.
, vol.49
, pp. 35-42
-
-
Schneider, J.1
Philipp, M.2
Salewski, L.3
Velcovsky, H.G.4
-
17
-
-
0037314212
-
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
-
Pujol, J.L.; Quantin, X.; Jacot, W.; Boher, J.M.; Grenier, J.; Lamy, P.J. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 2003, 39, 131-138.
-
(2003)
Lung Cancer
, vol.39
, pp. 131-138
-
-
Pujol, J.L.1
Quantin, X.2
Jacot, W.3
Boher, J.M.4
Grenier, J.5
Lamy, P.J.6
-
18
-
-
0035145078
-
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: Prospective study in 621 patients
-
Pujol, J.L.; Boher, J.M.; Grenier, J.; Quantin, X. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: Prospective study in 621 patients. Lung Cancer 2001, 31, 221-231.
-
(2001)
Lung Cancer
, vol.31
, pp. 221-231
-
-
Pujol, J.L.1
Boher, J.M.2
Grenier, J.3
Quantin, X.4
-
19
-
-
11144355182
-
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer
-
Barlesi, F.; Gimenez, C.; Torre, J.P.; Doddoli, C.; Mancini, J.; Greillier, L.; Roux, F.; Kleisbauer, J.P. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Respir. Med. 2004, 98, 357-362.
-
(2004)
Respir. Med.
, vol.98
, pp. 357-362
-
-
Barlesi, F.1
Gimenez, C.2
Torre, J.P.3
Doddoli, C.4
Mancini, J.5
Greillier, L.6
Roux, F.7
Kleisbauer, J.P.8
-
20
-
-
29244489499
-
The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer
-
Nisman, B.; Heching, N.; Biran, H.; Barak, V.; Peretz, T. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Tumour. Biol. 2006, 27, 8-16.
-
(2006)
Tumour. Biol.
, vol.27
, pp. 8-16
-
-
Nisman, B.1
Heching, N.2
Biran, H.3
Barak, V.4
Peretz, T.5
-
21
-
-
17744389363
-
Association d'Enseignement et de Recherche des Internes en Oncologie. Brain metastases at the time of presentation of non-small cell lung cancer: A multi-centric AERIO analysis of prognostic factors
-
Jacot, W.; Quantin, X.; Boher, J.M.; Andre, F.; Moreau, L.; Gainet, M.; Depierre, A.; Quoix, E.; Chevalier T.L.; Pujol, J.L. Association d'Enseignement et de Recherche des Internes en Oncologie. Brain metastases at the time of presentation of non-small cell lung cancer: A multi-centric AERIO analysis of prognostic factors. Br. J. Cancer 2001, 84, 903-909.
-
(2001)
Br. J. Cancer
, vol.84
, pp. 903-909
-
-
Jacot, W.1
Quantin, X.2
Boher, J.M.3
Andre, F.4
Moreau, L.5
Gainet, M.6
Depierre, A.7
Quoix, E.8
Chevalier, T.L.9
Pujol, J.L.10
-
22
-
-
0036257505
-
Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
-
Reinmuth, N.; Brandt, B.; Semik, M.; et al. Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer 2002, 36, 265-270.
-
(2002)
Lung Cancer
, vol.36
, pp. 265-270
-
-
Reinmuth, N.1
Brandt, B.2
Semik, M.3
-
23
-
-
9344265211
-
Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer
-
Diez, M.; Torres, A.; Maestro, M.L.; Ortega, M.D.; Gómez, A.; Pollán, M.; Lopez, J.A.; Picardo, A.; Hernando, F.; Balibrea, J.L. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer. Br. J. Cancer 1996, 73, 1248-1254.
-
(1996)
Br. J. Cancer
, vol.73
, pp. 1248-1254
-
-
Diez, M.1
Torres, A.2
Maestro, M.L.3
Ortega, M.D.4
Gómez, A.5
Pollán, M.6
Lopez, J.A.7
Picardo, A.8
Hernando, F.9
Balibrea, J.L.10
-
24
-
-
0028963398
-
Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer
-
Diez, M.; Gomez, A.; Hernando, F.; Ortega, M.D.; Gómez, A.; Pollán, M.; Lopez, J.A.; Picardo, A.; Hernando, F.; Balibrea, J.L. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer. Int. J. Biol. Markers 1995, 10, 5-10.
-
(1995)
Int. J. Biol. Markers
, vol.10
, pp. 5-10
-
-
Diez, M.1
Gomez, A.2
Hernando, F.3
Ortega, M.D.4
Gómez, A.5
Pollán, M.6
Lopez, J.A.7
Picardo, A.8
Hernando, F.9
Balibrea, J.L.10
-
25
-
-
0036174578
-
Prognostic value of serum tumor markers in patients with lung cancer
-
Hatzakis, K.D.; Froudarakis, M.E.; Bouros, D.; Tzanakis, N.; Karkavitsas, N.; Siafakas, N.M. Prognostic value of serum tumor markers in patients with lung cancer. Respiration 2002, 69, 25-29.
-
(2002)
Respiration
, vol.69
, pp. 25-29
-
-
Hatzakis, K.D.1
Froudarakis, M.E.2
Bouros, D.3
Tzanakis, N.4
Karkavitsas, N.5
Siafakas, N.M.6
-
26
-
-
0042529193
-
Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer
-
Gaspar, M.J.; Diez, M.; Rodriguez, A.; Ratia, T.; Martin, D.A.; Galvan, M.; Granell, J.; Coca, C. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Anticancer Res. 2003, 23, 3427-3432.
-
(2003)
Anticancer Res.
, vol.23
, pp. 3427-3432
-
-
Gaspar, M.J.1
Diez, M.2
Rodriguez, A.3
Ratia, T.4
Martin, D.A.5
Galvan, M.6
Granell, J.7
Coca, C.8
-
27
-
-
67651152754
-
Increased serum CA-125 levels in patients with lung cancer post thoracotomy
-
Nuñez, G.R.; Ito, C.; Del Giglio, A. Increased serum CA-125 levels in patients with lung cancer post thoracotomy. South Med. J. 2009, 102, 427-428.
-
(2009)
South Med. J.
, vol.102
, pp. 427-428
-
-
Nuñez, G.R.1
Ito, C.2
del Giglio, A.3
-
28
-
-
0033002559
-
Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer
-
Foa, P.; Fornier, M.; Miceli, R.; Seregni, E.; Santambrogio, L.; Nosotti, M.; Massaron, S.; Cataldo, I.; Oldani, S.; Iurlo, A.; et al. Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer. Int. J. Biol. Markers 1999, 14, 92-98.
-
(1999)
Int. J. Biol. Markers
, vol.14
, pp. 92-98
-
-
Foa, P.1
Fornier, M.2
Miceli, R.3
Seregni, E.4
Santambrogio, L.5
Nosotti, M.6
Massaron, S.7
Cataldo, I.8
Oldani, S.9
Iurlo, A.10
-
29
-
-
35748940008
-
Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer
-
Mizuguchi, S.; Nishiyama, N.; Iwata, T.; Nishida, T.; Izumi, N.; Tsukioka, T.; Inoue, K.; Uenishi, T.; Wakasa, K.; Suehiro, S. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer 2007, 58, 369-375.
-
(2007)
Lung Cancer
, vol.58
, pp. 369-375
-
-
Mizuguchi, S.1
Nishiyama, N.2
Iwata, T.3
Nishida, T.4
Izumi, N.5
Tsukioka, T.6
Inoue, K.7
Uenishi, T.8
Wakasa, K.9
Suehiro, S.10
-
30
-
-
0033428435
-
Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer
-
Foa, P.; Fornier, M.; Miceli, R.; Seregni, E.; Santambrogio, L.; Nosotti, M.; Cataldo, I.; Sala, M.; Caldiera, S.; Bombardieri, E. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Anticancer Res. 1999, 19, 3613-3618.
-
(1999)
Anticancer Res.
, vol.19
, pp. 3613-3618
-
-
Foa, P.1
Fornier, M.2
Miceli, R.3
Seregni, E.4
Santambrogio, L.5
Nosotti, M.6
Cataldo, I.7
Sala, M.8
Caldiera, S.9
Bombardieri, E.10
-
31
-
-
84866761739
-
Biomarkers in the lung cancer diagnosis: A clinical perspective
-
Li, X.; Asmitananda, T.; Gao, L.; Seregni, E.; Santambrogio, L.; Nosotti, M.; Cataldo, I.; Sala, M.; Caldiera, S.; Bombardieri, E. Biomarkers in the lung cancer diagnosis: A clinical perspective. Neoplasma 2012, 59, 500-507.
-
(2012)
Neoplasma
, vol.59
, pp. 500-507
-
-
Li, X.1
Asmitananda, T.2
Gao, L.3
Seregni, E.4
Santambrogio, L.5
Nosotti, M.6
Cataldo, I.7
Sala, M.8
Caldiera, S.9
Bombardieri, E.10
-
32
-
-
34447268726
-
Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib
-
Chiu, C.H.; Shih, Y.N.; Tsai, C.M.; Liou, J.L.; Chen, Y.M.; Perng, R.P. Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib. Lung Cancer 2007, 57, 213-221.
-
(2007)
Lung Cancer
, vol.57
, pp. 213-221
-
-
Chiu, C.H.1
Shih, Y.N.2
Tsai, C.M.3
Liou, J.L.4
Chen, Y.M.5
Perng, R.P.6
-
33
-
-
84862844389
-
The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited
-
Ma, S.; Shen, L.; Qian, N.; Chen, K. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Cancer Biomark. 2011-2012, 10, 155-162.
-
(2011)
Cancer Biomark
, vol.10
, pp. 155-162
-
-
Ma, S.1
Shen, L.2
Qian, N.3
Chen, K.4
-
34
-
-
84865431357
-
Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer
-
Tomita, M.; Shimizu, T.; Ayabe, T.; Onitsuka, T. Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer. Asia Pac. J. Clin. Oncol. 2012, 8, 244-247.
-
(2012)
Asia Pac. J. Clin. Oncol.
, vol.8
, pp. 244-247
-
-
Tomita, M.1
Shimizu, T.2
Ayabe, T.3
Onitsuka, T.4
-
35
-
-
84859435256
-
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
-
Grunnet, M.; Sorensen, J.B. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 2012, 76, 138-143.
-
(2012)
Lung Cancer
, vol.76
, pp. 138-143
-
-
Grunnet, M.1
Sorensen, J.B.2
-
36
-
-
35348885056
-
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer
-
Cho, W.C. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed. Pharmacother. 2007, 61, 515-519.
-
(2007)
Biomed. Pharmacother.
, vol.61
, pp. 515-519
-
-
Cho, W.C.1
|